Barely Significant
← all excerpts

Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations.

J Curr Glaucoma Pract · 2013 · PMC4741123 · PMID 26997776

Europe PMCDOI
1
hedged sentence
0.0490
closest p · 1.0× alpha
0.0490
boldest claim

The sentences

barely significantp = 0.049actually significant
In eyes receiving ranibizumab only the prevalence was 3.1% (3/96 eyes) and in eyes receiving bevacizumab only the prevalence was 9.9% (10/101 eyes), the difference between the two drugs barely significant (p = 0.049).

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.